arcus biosciences stock buy or sell

Friday, October 28, 2022 Edit

The current projected Arcus Biosciences target price consensus is. RCUS Stock Price Prediction 4743 7804 Upside Based on 7 Wall Street analysts offering 12 month price targets for Arcus Biosciences in the last 3 months.

Arcus Biosciences Inc Rcus Stock Price Today Quote News Seeking Alpha

Over the last 12.

. Its Value Score of C indicates it would be a neutral pick for value investors. Most readers would already be aware that Arcus Biosciences NYSERCUS stock increased significantly by 40 over the past month. However we wonder if the companys.

Valuation metrics show that Arcus Biosciences Inc. Is Arcus Biosciences stock a Buy Sell or Hold. The average Arcus Biosciences stock price prediction forecasts a potential.

NYSERCUS Get Rating by 544 during the 2nd quarter according to the. 15 hours agoIn other Arcus Biosciences news COO Jennifer Jarrett sold 12677 shares of Arcus Biosciences stock in a transaction on Friday September 16th. Arcus Biosciences Inc.

Lessened its holdings in shares of Arcus Biosciences Inc. The current analyst and expert consensus on Arcus Biosciences is Strong Buy with 0 strong sell and 7 strong buy opinions. Strong Buy 13 5 Buy Hold Sell Arcus Biosciences Stock.

Mirae Asset Global Investments Co. Arcus Biosciences share price volatility. RCUS stock price news buy or sell recommendation and investing advice from Wall Street professionals.

Stock price up more than 578 on Friday Updated on Oct 21 2022 Buy or Hold candidate since 2022-10-17 Gain 215 PDF The Arcus Biosciences Inc. May be fairly valued. Arcus Biosciences is a biopharmaceutical company.

RCUS buy or sellWhat is RCUS Finny Score. Arcus Biosciences Stock Rating What analysts recommend for RCUS stock on a scale from 1 buy to 5 sell. 1 day agoInsider Transactions at Arcus Biosciences.

Were not expecting Arcus Biosciences to pay a dividend over the next 12 months. Check out the forecast and prediction here. The average price target is.

Get the latest Arcus Biosciences Inc. NYSERCUS Shares Sold by SG Americas Securities LLC at ETF Daily News. In other news COO Jennifer Jarrett sold 12677 shares of the stock in a transaction on Friday September 16th.

The average rating score is and is based on 12 buy ratings. On average Wall Street analysts predict that Arcus Biosciences s share price could reach 5450 by Oct 11 2023. Arcus Biosciences stock has received a consensus rating of buy.

According to the issued ratings of 8 analysts in the last year the consensus rating for Arcus Biosciences stock is Buy based on the current 8 buy ratings for RCUS. Read Arcus Biosciences Inc. The firm owned 37557 shares of the companys stock after selling.

It focused on creating innovative cancer immunotherapies. Arcus Biosciences share dividends. Is Arcus Biosciences Inc NYSERCUS stock a buy or a sell.

Arcus Biosciences is a biotech company located in California United States which is part of the Healthcare sector and is traded under the ticker RCUS on the NYSE exchange. The stock was sold at. Our quantitative analysis shows 3 reasons to buy and 2 reasons to sell RCUS resulting in Finny Score of 60.

The stock was sold at an. Currently Arcus Biosciences Incs price-earnings ratio is 1934. Arcus Biosciences Incs trailing 12-month revenue is 4087 million with a 163 profit margin.

The companys product portfolio includes AB928 AB122 AB154 and. The financial health and. Macroaxis provides Arcus Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RCUS.

Rcus Arcus Biosciences Inc Stock Financial Analysis